Statin deprescribing ‘ups event rates’ in elderly
A population-based study in patients with polypharmacy shows an increased risk of death.
A population-based study in patients with polypharmacy shows an increased risk of death.
Study of single patients finds muscle symptoms are 'no higher' when they take atorvastatin compared with placebo.
Percentage reductions can be even greater at low LDL for some drugs, authors report.
Shared decision-making better when doctors know the time-to-benefit with statins, authors sayÂ
More data has emerged that lowering LDL cholesterol in old age reduces CV events.
Small trial shows regression of several plaque components, authors report.
Risk of dying from a cardiovascular event is 20% lower in those on the drugs, US study shows.
Lipophilic statins seem to have the strongest association, researchers say.
Randomised controlled trials need to be done to confirm the findings, UK researchers say.
Australian study shows the greatest protective effect was in men and patients with ulcerated primary melanoma.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.